๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I study of weekly docetaxel in patients with advanced refractory cancer

โœ Scribed by Takada, M; Yana, T; Sakai, S; Tsukiyama, S; Higuchi, K; Ueda, T; Ohashi, K; Hikita, T; Kishino, B; Nakagawa, K; Yamamoto, N; Fukuoka, M


Book ID
118569747
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
207 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase I trial of weekly docetaxel and ge
โœ Tarek Mekhail; Thomas E. Hutson; Paul Elson; G. Thomas Budd; Gordon Srkalovic; T ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND A Phase I study using weekly docetaxel and gemcitabine was conducted to investigate toxicity; to determine the maximum tolerated dose (MTD) of each agent; and, in a preliminary fashion, to determine the antitumor activity of the combination. ## METHODS Docetaxel and gem